Houston Concierge Medicine & Wellness Center

What we still need to verify: GLP-1/peptide sourcing unconfirmed — sixth consecutive check stuck here (2026-09-24, 2026-09-25, 2026-10-07, 2026-10-11, 2026-10-13, 2026-10-15) on sourcing alone. Rechecked 2026-10-07: homepage, /weight-loss1, /peptide-therapy, /meet-the-doctors and /weight-loss-services via curl (all HTTP 200). /weight-loss1 now says only that 'semaglutide and tirzepatide may be considered' — still no Wegovy/Ozempic/Zepbound/Mounjaro and no brand-vs-compounded statement; no research peptides named. Provider Gregory Burzynski, MD remains NPI-verified (Houston, TX; Katy Fwy); rating still 4.7 (177 reviews, Birdeye). Outreach email already queued in data/outreach-queue.md (ready to send) — a clinic reply is the only remaining path. Rechecked 2026-10-11: homepage, /weight-loss1, /peptide-therapy, /weight-loss-services via curl (HTTP 200) — unchanged: 'semaglutide and tirzepatide may be considered', no brand names, no brand-vs-compounded statement, no research peptides named. NPI Registry responded (Burzynski active, 9432 Katy Fwy, Houston). Rechecked 2026-10-13: /weight-loss1, /weight-loss-services, /peptide-therapy via curl (HTTP 200) — unchanged ('may be considered', no brand names, no brand-vs-compounded statement); NPI Registry responded (Burzynski active, 9432 Katy Fwy). Rechecked 2026-10-15: home, /weight-loss1, /weight-loss-services, /peptide-therapy, /faq via curl (HTTP 200) — unchanged, no brand names, no compounded statement, no research peptides; NPI Registry responded (Burzynski active, 9432 Katy Fwy). Awaiting clinic reply to queued outreach..
This clinic meets part of our standard, but at least one item is still unverified. We publish what we found and what is missing — transparency is the point.